PI3K pathway activation mediates resistance to MEK inhibitors in KRAS mutant cancers

S Wee, Z Jagani, KX Xiang, A Loo, M Dorsch, YM Yao… - Cancer research, 2009 - AACR
The RAS pathway is one of the most frequently deregulated pathways in cancer. RAS
signals through multiple effector pathways, including the RAF/mitogen-activated protein …
被引用次数：495 相关文章

PI3K pathway activation mediates resistance to MEK inhibitors in KRAS mutant cancers.

S Wee, Z Jagani, KX Xiang, A Loo, M Dorsch… - Cancer …, 2009 - europepmc.org
The RAS pathway is one of the most frequently deregulated pathways in cancer. RAS
signals through multiple effector pathways, including the RAF/mitogen-activated protein …

PI3K pathway activation mediates resistance to MEK inhibitors in KRAS mutant cancers

S Wee, Z Jagani, KX Xiang, A Loo… - Cancer …, 2009 - pubmed.ncbi.nlm.nih.gov
The RAS pathway is one of the most frequently deregulated pathways in cancer. RAS
signals through multiple effector pathways, including the RAF/mitogen-activated protein …
[PDF] academia.edu

[PDF][PDF] PI3K Pathway Activation Mediates Resistance to MEK Inhibitors in KRAS Mutant Cancers

S Wee, Z Jagani, KX Xiang, A Loo, M Dorsch, YM Yao… - academia.edu
The RAS pathway is one of the most frequently deregulated pathways in cancer. RAS
signals through multiple effector pathways, including the RAF/mitogen-activated protein …

[引用][C] P13K Pathway Activation Mediates Resistance to MEK Inhibitors in KRAS Mutant Cancers

S WEE, Z JAGANI, K XIAOQIN XIANG… - Cancer research …, 2009 - pascal-francis.inist.fr
P13K Pathway Activation Mediates Resistance to MEK Inhibitors in KRAS Mutant Cancers
CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search …
[PDF] archive.org

[PDF][PDF] PI3K Pathway Activation Mediates Resistance to MEK Inhibitors in KRAS Mutant Cancers

S Wee, Z Jagani, KX Xiang, A Loo, M Dorsch, YM Yao… - scholar.archive.org
The RAS pathway is one of the most frequently deregulated pathways in cancer. RAS
signals through multiple effector pathways, including the RAF/mitogen-activated protein …

PI3K pathway activation mediates resistance to MEK inhibitors in KRAS mutant cancers

S Wee, Z Jagani, XX Kay, A Loo, M Dorsch… - Cancer …, 2009 - pure.johnshopkins.edu
The RAS pathway is one of the most frequently deregulated pathways in cancer. RAS
signals through multiple effector pathways, including the RAF/mitogen-activated protein …
[PDF] semanticscholar.org

[PDF][PDF] PI3K Pathway Activation Mediates Resistance to MEK Inhibitors in KRAS Mutant Cancers

S Wee, Z Jagani, KX Xiang, A Loo, M Dorsch, YM Yao… - pdfs.semanticscholar.org
The RAS pathway is one of the most frequently deregulated pathways in cancer. RAS
signals through multiple effector pathways, including the RAF/mitogen-activated protein …

PI3K Pathway Activation Mediates Resistance to MEK Inhibitors in KRAS Mutant Cancers

S Wee, Z Jagani, KX Xiang, A Loo, M Dorsch… - Cancer …, 2009 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> The RAS pathway is one of the most frequently
deregulated pathways in cancer. RAS signals through multiple effector pathways, including …

[引用][C] P13K Pathway Activation Mediates Resistance to MEK Inhibitors in KRAS Mutant Cancers

S WEE, Z JAGANI… - Cancer …, 2009 - American Association for Cancer …